MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BIIB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Biogen (BIIB) Ownership - Who owns Biogen?

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7500
Web
https://www.biogen.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
28.68B
P/E Ratio
20.89
Total Cash
4.28B
Projected Growth
3.94
Total Debt
6.56B
Revenue
9.94B
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash/Share
29.01
Total Debt/Equity
6.50
Revenue/Share
67.35 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BIIB
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BIIB
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7500
Web
https://www.biogen.com